Recruiting
Phase 1
Phase 2

Observational Study

Sponsor:

MBrace Therapeutics

Code:

NCT07145255

Conditions

Prostate Cancer Castration-resistant Prostate Cancer

Breast Cancer

Colo-rectal Cancer

Lung Cancer (Non-Small Cell)

Pancreas Cancer, Duct Cell Adenocarcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ADC

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-12-30. This information was provided to ClinicalTrials.gov by MBrace Therapeutics on 2025-10-31.